Moderna extends lipids deal to boost COVID-19 vaccine candidate output
(Reuters Health)

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine as the U.S. biotech looks to build capacity and produce enough doses to meet expected global demand.